Koers Goodbody Health Canadian Securities Exchange
Aandelen
SWEL
CA3821591011
Farmaceutische producten
Omzet 2020 | 1,99 mln. 2,5 mln. 3,42 mln. 2,32 mln. | Omzet 2021 | 17,06 mln. 21,42 mln. 29,28 mln. 19,85 mln. | Marktkapitalisatie | 13,76 mln. 17,28 mln. 23,61 mln. 16,01 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -4 mln. -5,02 mln. -6,87 mln. -4,66 mln. | Nettowinst (verlies) 2021 | -2 mln. -2,51 mln. -3,43 mln. -2,33 mln. | EV/omzet 2020 | 5,41 x |
Nettoliquiditeiten 2020 | 1,37 mln. 1,72 mln. 2,36 mln. 1,6 mln. | Nettoliquiditeiten 2021 | 5,73 mln. 7,2 mln. 9,84 mln. 6,67 mln. | EV/omzet 2021 | 0,47 x |
K/w-verhouding 2020 |
-1,4
x | K/w-verhouding 2021 |
-5,64
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 70,26% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 26-01-21 |
Geremy Thomas
FOU | Founder | 64 | 14-02-11 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 14-02-11 |
George Thomas
CEO | Chief Executive Officer | 35 | 26-01-21 |
Anne Tew
SEC | Corporate Secretary | - | 01-11-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,17% | 6,16 mld. | |
-14,69% | 4,46 mld. | |
-8,17% | 3,27 mld. | |
+6,95% | 3,2 mld. | |
-1,76% | 2,6 mld. | |
+50,20% | 1,98 mld. | |
-7,85% | 1,7 mld. | |
-0,40% | 1,66 mld. | |
-9,91% | 1,61 mld. |